These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17653836)

  • 1. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.
    Savic RM; Jonker DM; Kerbusch T; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):711-26. PubMed ID: 17653836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
    Tortorici MA; Cohen EE; Pithavala YK; Garrett M; Ruiz-Garcia A; Kim S; Fruehauf JP
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1279-89. PubMed ID: 25336084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral absorption models for pregabalin: usefulness of transit compartment model.
    Hong T; Han S; Lee J; Jeon S; Yim DS
    Drug Des Devel Ther; 2016; 10():3995-4003. PubMed ID: 27994441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis.
    Milán Segovia RC; Domínguez Ramírez AM; Jung Cook H; Magaña Aquino M; Vigna Pérez M; Brundage RC; Romano Moreno S
    J Clin Pharm Ther; 2013 Feb; 38(1):56-61. PubMed ID: 23167603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies.
    De Buck SS; Jakab A; Boehm M; Bootle D; Juric D; Quadt C; Goggin TK
    Br J Clin Pharmacol; 2014 Sep; 78(3):543-55. PubMed ID: 24617631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidine.
    Trocóniz IF; de Alwis DP; Tillmann C; Callies S; Mitchell M; Schaefer HG
    Clin Pharmacol Ther; 2000 Jul; 68(1):18-27. PubMed ID: 10945312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady state investigation of possible pharmacokinetic interactions of moxonidine and glibenclamide.
    Müller M; Weimann HJ; Eden G; Weber W; Michaelis K; Dilger C; Achtert G
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):277-83. PubMed ID: 8149947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modeling of furosemide in patients with hypertension and fluid overload conditions.
    Kodati D; Yellu N
    Pharmacol Rep; 2017 Jun; 69(3):492-496. PubMed ID: 28340405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers].
    Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ
    Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
    Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
    Musuamba FT; Mourad M; Haufroid V; Demeyer M; Capron A; Delattre IK; Delaruelle F; Wallemacq P; Verbeeck RK
    J Clin Pharmacol; 2012 Dec; 52(12):1833-43. PubMed ID: 22207766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trials.
    Othman AA; Nothaft W; Awni WM; Dutta S
    J Clin Pharmacol; 2012 Jul; 52(7):1028-41. PubMed ID: 21566201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
    Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
    Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
    Osterberg O; Savic RM; Karlsson MO; Simonsson US; Nørgaard JP; Walle JV; Agersø H
    J Clin Pharmacol; 2006 Oct; 46(10):1204-11. PubMed ID: 16988210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies.
    Florian JA; Tornøe CW; Brundage R; Parekh A; Garnett CE
    J Clin Pharmacol; 2011 Aug; 51(8):1152-62. PubMed ID: 21228407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
    Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
    Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
    Guo F; Letrent SP; Sharma A
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.